Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Constance Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Constance Therapeutics

Constance Therapeutics

Constance Therapeutics: Whole-plant cannabis extracts for integrative treatment alternatives.

HQ
San Francisco, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Constance Therapeutics focuses on providing whole-plant cannabis extracts as part of an integrative approach to treatment. Their mission is to offer expanded treatment options for physicians and patients, particularly in cases where traditional pharmaceuticals may have been the only choice. By leveraging their polymorphic approach to extracts, Constance Therapeutics aims to redefine the landscape of alternative pharmaceutical treatments.

Constance Therapeutics has made significant strides in the field of integrative medicine, offering unique cannabis-based solutions that have garnered attention within the medical community. Their innovative approach has positioned them as a key player in the alternative pharmaceutical market, contributing to broader acceptance and utilization of cannabis extracts in medical treatments.

Constance Therapeutics - Similar Companies

Grassp Health logo

Grassp Health

Whole Plants logo

Whole Plants

Alternate Health logo

Alternate Health

Natural State Medical Group logo

Natural State Medical Group

PharmaCann logo

PharmaCann

pharmacann.com

TreatmentX logo

TreatmentX

treatmentx.com

Wellcana logo

Wellcana

Canaria Therapeutics logo

Canaria Therapeutics

Cannformatics logo

Cannformatics

cannformatics.com

Colorado Hemp Institute logo

Colorado Hemp Institute

THC Farmaceuticals logo

THC Farmaceuticals

toke.city

Harvest Direct Enterprises logo

Harvest Direct Enterprises

Emerald Health Bioceuticals logo

Emerald Health Bioceuticals

Resonate Blends logo

Resonate Blends

resonateblends.com

Pure Green Pharmaceuticals logo

Pure Green Pharmaceuticals

pgpharma.co

Constance Therapeutics - Quick Facts

Who are Constance Therapeutics' competitors?

Companies similar to Constance Therapeutics include Grassp Health, Whole Plants, Alternate Health and Natural State Medical Group.

When was Constance Therapeutics founded?

Constance Therapeutics was founded in 2015.

Where is Constance Therapeutics' headquarters located?

Constance Therapeutics' headquarters is located in San Francisco, CA, US.

When was Constance Therapeutics' last funding round?

Constance Therapeutics' most recent funding round was for $4.2M (USD) in February 2018.

How much has Constance Therapeutics raised to-date?

As of Feb 23, 2018, Constance Therapeutics has raised a total of $4.7M (USD).

How many employees does Constance Therapeutics have?

Constance Therapeutics has 30 employees as of Feb 5, 2024.

Constance Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Cannabis Extracts
Tags
  • Healthtech
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 620000Health Care and Social Assistance